Article Versions Notes

Shostak Y, Kramer MR, Edni O, Glusman Bendersky A, Shafran N, Bakal I, Heching M, Rosengarten D, Shitenberg D, Amor SM, et al. Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study. Vaccines. 2023; 11(4):799. https://doi.org/10.3390/vaccines11040799

Shostak, Yael, Mordechai R. Kramer, Omer Edni, Ahinoam Glusman Bendersky, Noa Shafran, Ilana Bakal, Moshe Heching, Dror Rosengarten, Dorit Shitenberg, Shay M. Amor, and et al. 2023. "Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study" Vaccines 11, no. 4: 799. https://doi.org/10.3390/vaccines11040799

Shostak, Y., Kramer, M. R., Edni, O., Glusman Bendersky, A., Shafran, N., Bakal, I., Heching, M., Rosengarten, D., Shitenberg, D., Amor, S. M., Ben Zvi, H., Pertzov, B., Cohen, H., Rotem, S., Elia, U., Chitlaru, T., Erez, N., Peysakhovich, Y., D. Barac, Y., ... Shtraichman, O. (2023). Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients—A Prospective Cohort Study. Vaccines, 11(4), 799. https://doi.org/10.3390/vaccines11040799